MetaCap

Outset Medical Inc. (OM)

NASDAQ: OMHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD

2.81-0.10 (-3.44%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

OM stock chart

Technical analysis

Key statistics

All statistics
Market cap
$53.03M
EPS (TTM)
-$3.78
52-week range
2.77 – 6.49
Day range
2.77 – 3.02
Volume / Avg
81.32K / 140.40K
Beta
—

52-week range

$2.77$6.49

OM stock today

On Nov 20, OM ended the session at $2.81, shedding $0.10 (3.44%), versus the S&P 500's 3.70% decline. At this level, OM sits near the bottom of its 52-week range of $2.77 to $6.49: 56.7% below the high, set on Jan 12, 2026 and 1.4% above the low. OM is down 24.3% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 34.5%.

Outset Medical has posted a net loss over the last twelve months (EPS of -$3.78), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Outset Medical

Company profile

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also offers Tablo Data Ecosystem, including TabloHub, a consumer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform.

Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
CEO
Ms. Leslie L. Trigg
Headquarters
San Jose, CA
Employees
310
IPO year
2020

Financial highlights

Full financials

In fiscal 2025, Outset Medical generated $119.5 million in revenue, up 5.1% from fiscal 2024. Outset Medical reported a net loss of $81.7 million, compared with a loss of $128.0 million a year earlier. Gross margin was 39.1% (up from 33.9%) and operating margin -55.8%.

Outset Medical annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$119.48M$113.69M$130.38M$115.38M$102.60M
Growth+5.09%-12.80%+13.00%+12.45%+105.47%
Net income$-81.65M$-127.98M$-172.80M$-162.96M$-131.94M
EPS (diluted)$-5.37$-36.96$-52.28$-3.38$-2.89

Analyst forecast

Forecast

Consensus (3 analysts)

buy

Avg. price target

$7.67+172.95%

  • Strong buy 0
  • Buy 2
  • Hold 1
  • Sell 0
  • Strong sell 0

Target range

Low $6.00High $10.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 4, 2026
EPS actual vs est.
$-0.78 vs $-0.84
Surprise
+7.14%

OM news

All OM news

Outset Medical peers

Health Care sector
OM peer companies
CompanyPrice% ChgMarket capCompare
HYPRHyperfine Inc. Class A0.5465+4.27%$57.96Mvs OM
NRXSNeuraxis Inc.4.22-6.22%$59.90Mvs OM
POCIPrecision Optics Corporation Inc.4.12+1.41%$45.30Mvs OM
ECORelectroCore Inc.4.42-8.87%$40.78Mvs OM
QTIQT Imaging Holdings Inc.1.92+2.67%$28.21Mvs OM
HSDTSolana Company Class A1.49-10.24%$93.70Mvs OM
ITOCiTonic Holdings Ltd Class A1.59+6.00%$11.63Mvs OM
STXSStereotaxis Inc.0.9422-6.71%$95.03Mvs OM

Indexes, lists and sector

Outset Medical stock FAQ

What is Outset Medical's stock price today?

OM last traded at $2.81 as of Nov 20, 4:00 PM EST, down 3.44% on the day. Prices are delayed at least 15 minutes.

Does Outset Medical pay a dividend?

No. Outset Medical does not currently pay a regular cash dividend.

Who is Outset Medical's CEO?

Ms. Leslie L. Trigg is the chief executive officer of Outset Medical Inc., which has about 310 employees.

Has OM ever split its stock?

Yes. The most recent OM stock split was a 1-for-15 split on Mar 20, 2025.

What is the OM 52-week high?

The 52-week high for OM is $6.49 and the 52-week low is $2.77. The stock is currently 56.7% below its high.

Compare OM